Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2017
Headcount
6
HQ
Israel
Sector
Health Tech & Life Sciences
About
Exscopia develops a technology that observes the indicator gases in breath with unprecedented sensitivity, in real-time, in reasonable size and cost for personal and institutional use. The compan is offering an absolute measurement in several seconds, non-invasive small device for personal use along with clinics high performance instrument for multiple compounds simultaneously. Exscopia aims at making the life of diabetics effortless and simple.
Q&A
- What is Exscopia's primary focus?
- Exscopia develops a non-invasive breath decoder for blood glucose metering, aiming to make life easier for diabetics.
- When was Exscopia founded?
- Exscopia was founded in March 2017.
- What is the current status of Exscopia?
- Exscopia is currently inactive, having ceased operations in June 2019.
- Who is the founder and CEO of Exscopia?
- Michal Badash is the Founder & CEO of Exscopia.
- In which sector does Exscopia primarily operate?
- Exscopia's primary sector is Health Tech & Life Sciences.
- What kind of technology does Exscopia offer?
- Exscopia offers a technology that observes indicator gases in breath with high sensitivity for real-time, non-invasive measurements, suitable for personal and institutional use.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Tags
real-timenon-invasivemedical-devicesdiabetesstealthmode
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2017-3 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Jun 2019 ceased to operate |